GlaxoWellcome Production

Form 483

Evreux, -, FranceFEI 3002807436Issued March 03, 2017

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3002807436.

Observations1

Issue DateMarch 03, 2017

StatusNo Warning Letter

Related Inspections5

Establishment Details

Firm: GlaxoWellcome Production
Location: Evreux, -, France
FEI Number: 3002807436
Product Type: Drugs
Issue Date: March 03, 2017
Country: France

Inspection History, 2009 to 2022

NAI3

VAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

GlaxoWellcome Production FDA Form 483, Evreux, March 3, 2017